These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 16675522

  • 1. Neuroendocrine stress but not feeding responses to centrally administered neuropeptide Y are suppressed in pregnant rats.
    Brunton PJ, Bales J, Russell JA.
    Endocrinology; 2006 Aug; 147(8):3737-45. PubMed ID: 16675522
    [Abstract] [Full Text] [Related]

  • 2. Central administration of cocaine-amphetamine-regulated transcript activates hypothalamic neuroendocrine neurons in the rat.
    Vrang N, Larsen PJ, Kristensen P, Tang-Christensen M.
    Endocrinology; 2000 Feb; 141(2):794-801. PubMed ID: 10650962
    [Abstract] [Full Text] [Related]

  • 3. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
    Larsen PJ, Tang-Christensen M, Jessop DS.
    Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
    [Abstract] [Full Text] [Related]

  • 4. Hypothalamic-pituitary-adrenal responses to centrally administered orexin-A are suppressed in pregnant rats.
    Brunton PJ, Russell JA.
    J Neuroendocrinol; 2003 Jul; 15(7):633-7. PubMed ID: 12787047
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine responses to stress in mice: hyporesponsiveness in pregnancy and parturition.
    Douglas AJ, Brunton PJ, Bosch OJ, Russell JA, Neumann ID.
    Endocrinology; 2003 Dec; 144(12):5268-76. PubMed ID: 12960085
    [Abstract] [Full Text] [Related]

  • 6. Reduced activity of the noradrenergic system in the paraventricular nucleus at the end of pregnancy: implications for stress hyporesponsiveness.
    Douglas AJ, Meddle SL, Toschi N, Bosch OJ, Neumann ID.
    J Neuroendocrinol; 2005 Jan; 17(1):40-8. PubMed ID: 15720474
    [Abstract] [Full Text] [Related]

  • 7. Centrally administered neuromedin U activates neurosecretion and induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat.
    Ozaki Y, Onaka T, Nakazato M, Saito J, Kanemoto K, Matsumoto T, Ueta Y.
    Endocrinology; 2002 Nov; 143(11):4320-9. PubMed ID: 12399428
    [Abstract] [Full Text] [Related]

  • 8. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity.
    Dimitrov EL, DeJoseph MR, Brownfield MS, Urban JH.
    Endocrinology; 2007 Aug; 148(8):3666-73. PubMed ID: 17463058
    [Abstract] [Full Text] [Related]

  • 9. Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats.
    Neumann ID, Torner L, Wigger A.
    Neuroscience; 2000 Aug; 95(2):567-75. PubMed ID: 10658637
    [Abstract] [Full Text] [Related]

  • 10. The role of endogenous opioids in neurohypophysial and hypothalamo-pituitary-adrenal axis hormone secretory responses to stress in pregnant rats.
    Douglas AJ, Johnstone HA, Wigger A, Landgraf R, Russell JA, Neumann ID.
    J Endocrinol; 1998 Aug; 158(2):285-93. PubMed ID: 9771473
    [Abstract] [Full Text] [Related]

  • 11. Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes.
    Neumann ID, Johnstone HA, Hatzinger M, Liebsch G, Shipston M, Russell JA, Landgraf R, Douglas AJ.
    J Physiol; 1998 Apr 01; 508 ( Pt 1)(Pt 1):289-300. PubMed ID: 9490853
    [Abstract] [Full Text] [Related]

  • 12. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
    Ochedalski T, Subburaju S, Wynn PC, Aguilera G.
    J Neuroendocrinol; 2007 Mar 01; 19(3):189-97. PubMed ID: 17280592
    [Abstract] [Full Text] [Related]

  • 13. Influence of the paraventricular nucleus of the hypothalamus in the alteration of neuroendocrine functions induced by intermittent footshock or interleukin.
    Rivest S, Rivier C.
    Endocrinology; 1991 Oct 01; 129(4):2049-57. PubMed ID: 1655391
    [Abstract] [Full Text] [Related]

  • 14. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats.
    Al-Barazanji KA, Wilson S, Baker J, Jessop DS, Harbuz MS.
    J Neuroendocrinol; 2001 May 01; 13(5):421-4. PubMed ID: 11328451
    [Abstract] [Full Text] [Related]

  • 15. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP, Wiegand SJ, Watson SJ.
    Endocrinology; 1990 Nov 01; 127(5):2408-17. PubMed ID: 2171915
    [Abstract] [Full Text] [Related]

  • 16. Endogenous opioids and attenuated hypothalamic-pituitary-adrenal axis responses to immune challenge in pregnant rats.
    Brunton PJ, Meddle SL, Ma S, Ochedalski T, Douglas AJ, Russell JA.
    J Neurosci; 2005 May 25; 25(21):5117-26. PubMed ID: 15917452
    [Abstract] [Full Text] [Related]

  • 17. Androgen inhibits, while oestrogen enhances, restraint-induced activation of neuropeptide neurones in the paraventricular nucleus of the hypothalamus.
    Lund TD, Munson DJ, Haldy ME, Handa RJ.
    J Neuroendocrinol; 2004 Mar 25; 16(3):272-8. PubMed ID: 15049858
    [Abstract] [Full Text] [Related]

  • 18. Hypothalamic and amygdaloid corticotropin-releasing hormone (CRH) and CRH receptor-1 mRNA expression in the stress-hyporesponsive late pregnant and early lactating rat.
    da Costa AP, Ma X, Ingram CD, Lightman SL, Aguilera G.
    Brain Res Mol Brain Res; 2001 Jul 13; 91(1-2):119-30. PubMed ID: 11457499
    [Abstract] [Full Text] [Related]

  • 19. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
    Kakui N, Kitamura K.
    Endocrinology; 2007 Jun 13; 148(6):2854-62. PubMed ID: 17363455
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S, Smith MA, Gold PW.
    Endocrinology; 1995 Aug 13; 136(8):3299-309. PubMed ID: 7628364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.